Market revenue in 2023 | USD 90,877.6 million |
Market revenue in 2030 | USD 125,837.2 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 71.96% in 2023. Horizon Databook has segmented the North America active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. Department of Health and Human Services is undertaking initiatives to raise awareness pertaining to cancer and other lifestyle diseases, such as diabetes & cardiovascular conditions. Increasing healthcare spending by the government and rising per capita income are some of the factors expected to significantly improve the market penetration of API production.
High cost of infrastructure and labor may restrict market growth. Impact of geopolitical scenarios such as the U.S. China trade war is expected to restrain market growth, as the region imports majority of the APIs from China. Stringent regulatory framework can slow down market growth. High dependence on other countries for API and raw materials may act as a threat to market growth in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America active pharmaceutical ingredients market , including forecasts for subscribers. This continent databook contains high-level insights into North America active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account